Drug Patent Expirations in December 2007

Drug Patent Expirations in December 2007

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in December 2007
*Drugs may be
covered by multiple patents

Tradename Applicant Generic Name Patent Number Patent Expiration
DOVONEX Leo Pharm calcipotriene 4,866,048 DEC 29,2007
FASLODEX Astrazeneca fulvestrant 4,659,516 DEC 11,2007
KYTRIL Roche granisetron hydrochloride 4,886,808 DEC 20,2007
KYTRIL Roche granisetron hydrochloride 4,886,808 DEC 29,2007
MERIDIA Abbott sibutramine hydrochloride 4,746,680 DEC 11,2007
REQUIP Glaxosmithkline ropinirole hydrochloride 4,452,808 DEC 07,2007
TACLONEX Leo Pharm Prods betamethasone dipropionate; calcipotriene hydrate 4,866,048 DEC 29,2007
ZINECARD Pharmacia And Upjohn dexrazoxane hydrochloride 4,963,551 DEC 21,2007
ZYRTEC Pfizer cetirizine hydrochloride 4,525,358 DEC 25,2007
ZYRTEC-D 12 HOUR Pfizer cetirizine hydrochloride; pseudoephedrine hydrochloride 4,525,358 DEC 25,2007

Courtesy of DrugPatentWatch.com

NO COMMENTS

  1. Extend the life of drugs with extended delivery formulations. Coreg CR developed by GSK/Flamel Technologies is an example.

Leave a Reply